-
Something wrong with this record ?
Reductive metabolism of tiaprofenic acid by the human liver and recombinant carbonyl reducing enzymes
P. Malátková, A. Skarka, K. Musilová, V. Wsól,
Language English Country Ireland
Document type Journal Article
- MeSH
- Alcohol Oxidoreductases chemistry genetics metabolism MeSH
- Biocatalysis MeSH
- Cytosol enzymology MeSH
- Short Chain Dehydrogenase-Reductases chemistry genetics metabolism MeSH
- Liver enzymology metabolism MeSH
- Kinetics MeSH
- Humans MeSH
- Microsomes enzymology MeSH
- Propionates chemistry metabolism MeSH
- Recombinant Proteins biosynthesis chemistry isolation & purification MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
Tiaprofenic acid is a widely used anti-inflammatory drug; however, the reductive metabolism of tiaprofenic acid is not yet well understood. Here, we compared the reduction of tiaprofenic acid in microsomes and cytosol from the human liver. The microsomes exhibited lower Km value toward tiaprofenic acid than the cytosol (Km = 164 ± 18 μM vs. 569 ± 74 μM, respectively), whereas the cytosol showed higher specific activity during reduction than the microsomes (Vmax = 728 ± 52 pmol mg of protein-1 min-1 vs. 285 ± 11 pmol mg of protein-1 min-1, respectively). Next, a panel of recombinant carbonyl reducing enzymes from AKR and SDR superfamilies has been studied to find the enzymes responsible for the cytosolic reduction of tiaprofenic acid. CBR1 was identified as the reductase of tiaprofenic acid with high specific activity (56,965 ± 6741 pmol mg of protein-1 min-1). Three other enzymes, AKR1A1, AKR1B10, and AKR1C4, were also able to reduce tiaprofenic acid, but with very low activity. Thus, CBR1 was shown to be a tiaprofenic acid reductase in vitro and was also suggested to be the principal tiaprofenic acid reductase in vivo.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18016713
- 003
- CZ-PrNML
- 005
- 20200131094748.0
- 007
- ta
- 008
- 180515s2017 ie f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.cbi.2017.03.006 $2 doi
- 035 __
- $a (PubMed)28322780
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ie
- 100 1_
- $a Malátková, Petra $u Department of Biochemical Sciences, Faculty of Pharmacy, Charles University, Heyrovského 1203, Hradec Králové, CZ-50005, Czech Republic. Electronic address: petra.malatkova@faf.cuni.cz.
- 245 10
- $a Reductive metabolism of tiaprofenic acid by the human liver and recombinant carbonyl reducing enzymes / $c P. Malátková, A. Skarka, K. Musilová, V. Wsól,
- 520 9_
- $a Tiaprofenic acid is a widely used anti-inflammatory drug; however, the reductive metabolism of tiaprofenic acid is not yet well understood. Here, we compared the reduction of tiaprofenic acid in microsomes and cytosol from the human liver. The microsomes exhibited lower Km value toward tiaprofenic acid than the cytosol (Km = 164 ± 18 μM vs. 569 ± 74 μM, respectively), whereas the cytosol showed higher specific activity during reduction than the microsomes (Vmax = 728 ± 52 pmol mg of protein-1 min-1 vs. 285 ± 11 pmol mg of protein-1 min-1, respectively). Next, a panel of recombinant carbonyl reducing enzymes from AKR and SDR superfamilies has been studied to find the enzymes responsible for the cytosolic reduction of tiaprofenic acid. CBR1 was identified as the reductase of tiaprofenic acid with high specific activity (56,965 ± 6741 pmol mg of protein-1 min-1). Three other enzymes, AKR1A1, AKR1B10, and AKR1C4, were also able to reduce tiaprofenic acid, but with very low activity. Thus, CBR1 was shown to be a tiaprofenic acid reductase in vitro and was also suggested to be the principal tiaprofenic acid reductase in vivo.
- 650 _2
- $a alkoholoxidoreduktasy $x chemie $x genetika $x metabolismus $7 D000429
- 650 _2
- $a biokatalýza $7 D055162
- 650 _2
- $a cytosol $x enzymologie $7 D003600
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a kinetika $7 D007700
- 650 _2
- $a játra $x enzymologie $x metabolismus $7 D008099
- 650 _2
- $a mikrozomy $x enzymologie $7 D008861
- 650 _2
- $a propionáty $x chemie $x metabolismus $7 D011422
- 650 _2
- $a rekombinantní proteiny $x biosyntéza $x chemie $x izolace a purifikace $7 D011994
- 650 _2
- $a dehydrogenasy/reduktasy s krátkým řetězcem $x chemie $x genetika $x metabolismus $7 D000074583
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Skarka, Adam $u Department of Biochemical Sciences, Faculty of Pharmacy, Charles University, Heyrovského 1203, Hradec Králové, CZ-50005, Czech Republic. Electronic address: skara3aa@faf.cuni.cz.
- 700 1_
- $a Musilová, Kateřina, $d 1991- $7 xx0244496 $u Department of Biochemical Sciences, Faculty of Pharmacy, Charles University, Heyrovského 1203, Hradec Králové, CZ-50005, Czech Republic. Electronic address: musilok2@faf.cuni.cz.
- 700 1_
- $a Wsól, Vladimír $u Department of Biochemical Sciences, Faculty of Pharmacy, Charles University, Heyrovského 1203, Hradec Králové, CZ-50005, Czech Republic. Electronic address: vladimir.wsol@faf.cuni.cz.
- 773 0_
- $w MED00002111 $t Chemico-biological interactions $x 1872-7786 $g Roč. 276, č. - (2017), s. 121-126
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28322780 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180515 $b ABA008
- 991 __
- $a 20200131095131 $b ABA008
- 999 __
- $a ok $b bmc $g 1300337 $s 1013553
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 276 $c - $d 121-126 $e 20170318 $i 1872-7786 $m Chemico-biological interactions $n Chem Biol Interact $x MED00002111
- LZP __
- $a Pubmed-20180515